Clostridium pasteurianum cell-free extracts enzymatically reduced metronidazole when coupled by hydrogenase via reduced ferredoxin. A 5 mM concentration of methyl viologen, flavin adenine dinucleotide, or flavin mononucleotide could completely replace ferredoxin (0.05 mM) in the in vitro reduction assay system, whereas 5 mM benzyl viologen was less effective. However, when these electron carriers were used at a concentration of 0.05 mM, there was a drastic loss in their abilities to couple the metronidazole reduction system compared with the comparable concentration of ferredoxin. It is not understood why these flavin coenzymes participate in this enzymatic reaction. NAD and NADP had no activity when substituted for ferredoxin in the enzyme system. Two reduced ferredoxin-linked pathways, "metronidazole reductase" and the inducible dissimilatory sulfite reductase system, when combined in a single in vitro competition experiment demonstrated a preferential flow of electrons to metronidazole away from sulfite. A proposed bactericidal mechanism for metronidazole against C. pasteurianum incorporating the above findings is discussed.
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Metronidazole, a 5-nitroimidazole, is an important bactericidal antibiotic for the treatment of anaerobic infections. This drug shows excellent selective toxicity towards bacterial species in the genera Bacteroides and Clostridium and in many other anaerobic microorganisms. Also, infections caused by protozoa such as Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia (G. intestinalis) are treated with metronidazole (19) .
The 5-nitro group on the imidazole ring has to be reduced for metronidazole to be biologically active (4, 5) . It has been suggested that the reduction of metronidazole is ferredoxin linked in anaerobic bacteria as a basis for its selective toxicity towards this group of microorganisms (3, 15, 20, 22) . However, conclusive evidence for the role of ferredoxin in the anaerobic reduction of metronidazole has not been reported. Thus it was of interest to investigate the effects of metronidazole upon two selected ferredoxin-linked pathways in a prototype microorganism, Clostridium pasteurianum.
Several characteristics of this microorganism make it appropriate for this kind of study. C. pasteurianum, a soil nonpathogen, belongs to the group I clostridia as defined in Bergey's Manual of Determinative Bacteriology (1) . They have subterminal spores and do not hydrolyze gelatin. However, C. pasteurianum is representative of group II pathogenic clostridial species in that it is a gram-positive obligate anaerobe and ferments a number of common sugars to butyric acid and acetic acid. It is also advantageous to work with as it will grow on both enriched and synthetic media and is the most biochemically studied of all clostridial species. It has several well-known ferredoxin-coupled enzymatic reductive pathways, including nitrogen fixation, the phosphoroclastic reaction, the hydrogenase pathway (23), and an inducible dissimilatory type of sulfite reduction pathway (8) .
In this communication we describe a nitro group reduction mechanism for metronidazole and its cytotoxic implications in C. pasteurianum. * Corresponding author.
MATERIALS AND METHODS
Culture conditions. C. pasteurianum strain W5 was grown in 10-liter batch cultures on a 1% sucrose-synthetic salts medium supplemented with either 1 mM S042-or 1 mM S032-plus 10 mM cysteine as the inorganic sulfur sources depending on experimental conditions (11) . Cells were harvested at mid-log-phase growth by a CEPA continuous-flow centrifuge. These cells were suspended in distilled water and centrifuged at 11,000 x g for 15 min at 5°C in a Sorvall RC-5 centrifuge. The supernatant was discarded and the pellet was saved for enzymatic assays.
Cell-free extracts. The pellets were suspended in distilled water (1.0 ml per g [wet weight] of cells) and this suspension was passed through an Aminco French pressure cell at about 10,000 lb/in2. After centrifugation at 37,500 x g for 15 min at 5°C, the supernatant, now referred to as the cell-free crude extract, was decanted and stored under hydrogen at -20°C.
Removal of ferredoxin from cell-free crude extract. Ferredoxin was removed from the cell-free crude extracts by a DEAE-cellulose titration procedure previously described (12, 14) . This crude extract was known as the DEAE-treated extract, which only lacked ferredoxin and possibly some other low-molecular-weight electron carriers.
Enzymatic assays. Metronidazole reduction by crude cellfree extract was followed by using an enzymatic coupling reaction system involving hydrogenase and the "metronidazole reductase" in which the uptake of hydrogen was measured by standard manometric techniques. The high specific activity of the hydrogenase in these extracts (21) indicated that the hydrogenase was always in excess. The complete reaction mixture in a double-sidearm Warburg flask contained the following: in the main compartment 0.2 ml of 1 mM phosphate buffer (pH 7.5), 0.1 ml of 2 mM MgCl2, cell-free crude extract (in a volume equivalent to 3 mg of protein) or DEAE-treated extract (in a volume equivalent to 3 mg of protein), and 0.2 ml of distilled water in one side arm or 5 pLmol of metronidazole in 0.2 ml of distilled water in the other side arm. The center well of the Warburg flask contained 0.2 ml of 40% NaOH, giving a total volume of 2.2 ml in the flask. The reaction was initiated by tipping the substrate metronidazole into the main compartment, and incubation was at 37°C under an atmosphere of hydrogen gas. Drug reduction was then followed over time by measuring the uptake of hydrogen gas. When the reaction was finished, the reaction mixture was centrifuged and the supernatant was examined for mnetronidazole nitro group reduction by partial or complete loss of the drug's absorption peak at 320 nm as measured with a Perkin-Elmer Lambda 3 scanning spectrophotometer. This qualitative spectrophotometric procedure was used because an assay for the cytotoxic end product of metronidazole's reduction has yet to be elucidated.
To study the preferential reduction of ferredoxin-linked reactions, metronidazole reductase versus the inducible dissimilatory sulfite reductase system (6a, 11), the sulfite reductase was assayed by standard manometric techniques described by Laishley et al. (12) and Harrison et al. (7) . The center well of the Warburg flask contained 0.2 ml of 40% NaOH to trap H2S, which was analyzed by the procedure of Jeng (D. Jeng, Ph.D. thesis, Purdue University, West Lafayette, Ind.). The cell-free crude extract (12 mg of protein) used in these experiments was prepared from cultures grown on 1 mM S032 plus 10 mM cysteine. When the substrates metronidazole and S032-were being compared together in the same Warburg flask for enzymatic activity, metronidazole (5 ,umol) and S032- (5 Chemicals. C. pasteurianum type V ferredoxin was obtained from Sigma Chemical Co. and metronidazole was from Rhone-Poulenc. All other chemicals were of reagentgrade quality. Protein. Protein concentrations were determined by the biuret procedure of Gornall et al. (6) . RESULTS Enzymatic reduction of metronidazole by cell-free extracts. C. pasteurianum cell-free crude extracts were capable of reducing metronidazole (Fig. 1) as measured by hydrogen uptake, which only occurred in the presence of the substrate e Ferredoxin concentration calculated from 6,000 molecular weight.
metronidazole. Preliminary experiments with crude cell-free extracts (3 mg of protein) gave a typical exponential Michaelis-Menton kinetic rate curve with respect to varying metronidazole concentrations (between 1 and 10 ,umol) in this reduction system. When the protein concentration in the assay mixture was tripled (to 9 mg), linear regression analysis of the slopes of the two reaction lines (Fig. 1) over the first 15 min showed a corresponding 3.5-fold rate increase in hydrogen uptake approximating first-order kinetics with respect to enzyme concentration. Both reaction mixtures were examined after 30 min for the presence of metronidazole, and the nitro group was judged to be reduced by the complete loss of its 320-nm absorbance peak. This qualitative analysis procedure indicated that the drug was probably entirely reduced under this enzymatic assay condition.
Ferredoxin requirements for the metronidazole reduction system. No hydrogen uptake occurs in the presence of metronidazole when ferredoxin is removed from the cell-free crude extract (Fig. 2) . When purified ferredoxin (in an amount necessary to achieve maximal specific acitivity) was added back to the DEAE-treated cell-free crude extract, the metronidazole reduction activity was restored to a higher specific activity than that present in the crude cell-free extract. The latter effect occurs because the amount of ferredoxin in the cell-free crude extract is not at saturating levels for the metronidazole reduction system. Saturation curve kinetics for the replacement of various concentrations of ferredoxin in the DEAE-cellulose-treated extract are shown in Fig. 3 . These experiments demonstrate that the metronidazole reduction system is ferredoxin linked.
However, several other electron carriers, depending upon their concentrations, gave comparable activity to ferredoxin in the DEAE-cellulose-treated extract assay system (Table  1) . These include the artificial low-potential electron carrier dyes methyl and benzyl viologen and the flavin coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). NAD and NADP gave no detectable enzyme activity even at higher (5 mM) electron carrier concentrations.
Preferential in vitro ferredoxin-linked reduction of metronidazole. A second ferredoxin-linked enzyme pathway used in these competition experiments was the C. pasteurianum inducible dissimilatory type of sulfite reductase system (11) . This reduction pathway also involves the coupling of hydrogenase to reduce ferredoxin for the subsequent enzymatic reduction of S032-to H2S. It was of interest to compare how these two ferredoxin-coupled systems would compete for electrons from reduced ferredoxin. This may aid in the further understanding of the bactericidal mechanism of action of this drug when used in clinical situations.
The results of this competition experiment are shown in Fig. 4 . It should be noted that the inducible S032-reductase system required a larger amount of cell-free crude extract (12 mg of protein) to obtain measurable linear enzyme activity over 30 min. In the enzyme assay with metronidazole alone as the substrate, rapid hydrogen uptake occurred for 15 min and then ceased. This indicated complete reduction of metronidazole which was confirmed after 30 min by the qualitative spectrophotometric analysis (see Materials and Methods). The stoichiometry of the reaction was such that for every 12 ixmol of hydrogen consumed 5 Fmol of metronidazole was reduced, giving an H2/metronidazole ratio of 2.4:1. In addition, no sulfide was detected during this reduction process.
Comparatively, in reaction mixtures with S032-alone, a slower but constant rate of reduction occurred over the 30 min. Also, considerable amounts of the end product sulfide were detected after 10 min and continued to be produced until the end of the experiment. The stoichiometry of this control system with S032-alone as a substrate gave the known theoretical 3:1 H2/S2-ratio for this reduction pathway (11; see competitive substrates to the enzyme reaction mixture, the rate of hydrogen uptake for the initial phase of the reaction resembled that for metronidazole alone. The rate of hydrogen uptake decreased for the latter phase of the reaction and approximated that for the reduction system using So32-alone. This change in the rate of hydrogen uptake occurred when it was judged that metronidazole was completely reduced. This suggests that metronidazole competed with S032-for available reducing equivalents from ferredoxin. Figure 4 also illustrates that there was threefold less sulfide produced at 10 min compared with that formed when So32-was used as the sole substrate. After 10 min, the rate of sulfide evolution increased approximately 5.6-fold to the end of the reaction time.
The stoichiometry (Fig. 4) further supports the preferential reduction of metronidazole in this competitive substrate system. The very high H21S2-ratio of 22:1 at 10 min versus 2.7:1 for the system with S032-alone shows that excess hydrogen is consumed as metronidazole is reduced. After 20 min the H2/S2-ratio falls approximately 50%, coinciding with the complete nitro group reduction of metronidazole.
DISCUSSION
Ferredoxin-linked reduction of metronidazole was demonstrated in C. pasteurianum cell-free crude extracts. Ferredoxin is the most important low-potential electron carrier in C. pasteurianum as it is approximately 0.1% of the cellular protein (9) . This concentration is far greater than that of any other electron carrier found in C. pasteurianum. This and the fact that we have shown that metronidazole is more efficiently reduced via ferredoxin compared with other electron carriers (Table 1 ) support the conclusion that metronidazole reduction in vivo is ferredoxin linked in C. pasteurianum.
At very low concentrations (0.05 mM) the low-potential electron carrier dyes methyl viologen and benzyl viologen and the flavin coenzymes FMN and FAD were much less efficient than a comparable concentration of ferredoxin. Methyl viologen has been shown to entirely substitute in vitro as the electron carrier in ferredoxin-coupled reactions (14) . However, in low concentration (0.10 ,umol) equivalent to the ferredoxin concentration for maximal activity (Fig. 3) , methyl viologen was only 8% as efficient. At high concentrations, FMN, FAD, methyl viologen, and to a lesser extent benzyl viologen could replace ferredoxin as electron carriers (Table 1 ). The finding that these flavin coenzymes, FMN and FAD (each with more positive 1-electron reduction potentials), could replace ferredoxin in the reduction of metronidazole was unexpected and is unexplained.
The stoichiometry of metronidazole reduction by crude cell-free extracts gave an H2/metronidazole ratio of 2.4:1, which supports an overall 4-electron reduction sequence of the 5-nitrogroup of metronidazole. This agrees with the data of other investigators (13, 18) .
In the competition studies involving the two ferredoxinlinked reactions, i.e., the inducible dissimilatory sulfite reductase and the metronidazole reductase systems, a siphoning of electrons from enzymatically reduced ferredoxin to metronidazole away from So32-occurred when both substrates were in competition for these reducing equivalents. These results indicate that metronidazole, once intracellular, acts as a preferential electron sink via reduced ferredoxin, diverting the flow of electrons from other normal metabolic reductive processes.
Rapid uptake of metronidazole across the anaerobic cell has been shown previously (16, 22) 169, 1983) .
The effective bactericidal activity of metronidazole against C. pasteurianum may be a two-stage mechanism. First, the rapid intracellular accumulation of metronidazole results in its preferential scavenging of electrons from reduced ferredoxin, depriving other ferredoxin-linked reduction systems of essential reducing equivalents. Second, the reduced metronidazole intermediate(s) then has a cytotoxic effect upon the host DNA (2, 10) , thereby preventing normal RNA transcription or DNA replication or both.
The selective toxicity of metronidazole towards anaerobic microorganisms may be caused in part by the nonspecific siphoning of electrons from essential ferredoxin-coupled reduction pathways in C. pasteurianum.
